Related Articles for PubMed (Select 18387177)

Killing cancer cells by targeted drug-carrying phage nanomedicines.

Bar H, Yacoby I, Benhar I.

BMC Biotechnol. 2008 Apr 3;8:37.

PMID: 18387177 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Tumor targeting using anti-her2 immunoliposomes.

Park JW, Kirpotin DB, Hong K, Shalaby R, Shao Y, Nielsen UB, Marks JD, Papahadjopoulos D, Benz CC.

J Control Release. 2001 Jul 6;74(1-3):95-113.

PMID: 11489487 [PubMed - indexed for MEDLINE]

Targeted filamentous bacteriophages as therapeutic agents.

Yacoby I, Benhar I.

Expert Opin Drug Deliv. 2008 Mar;5(3):321-9. Review.

PMID: 18318653 [PubMed - indexed for MEDLINE]

Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.

Liu Y, Miyoshi H, Nakamura M.

Int J Cancer. 2007 Jun 15;120(12):2527-37. Review.

PMID: 17390371 [PubMed - indexed for MEDLINE]

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene.

Ríhová B, Jelínková M, Strohalm J, St'astný M, Hovorka O, Plocová D, Kovár M, Dráberová L, Ulbrich K.

Bioconjug Chem. 2000 Sep-Oct;11(5):664-73.

PMID: 10995209 [PubMed - indexed for MEDLINE]

Targeted anti bacterial therapy.

Yacoby I, Benhar I.

Infect Disord Drug Targets. 2007 Sep;7(3):221-9. Review.

PMID: 17897058 [PubMed - indexed for MEDLINE]

10:

Designing polymer conjugates as lysosomotropic nanomedicines.

Duncan R.

Biochem Soc Trans. 2007 Feb;35(Pt 1):56-60. Review.

PMID: 17233601 [PubMed - indexed for MEDLINE]

11:

In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide.

Moon C, Kwon YM, Lee WK, Park YJ, Yang VC.

J Control Release. 2007 Dec 4;124(1-2):43-50. Epub 2007 Sep 5.

PMID: 17904680 [PubMed - indexed for MEDLINE]

12:

Targeted gene delivery to mammalian cells by filamentous bacteriophage.

Poul MA, Marks JD.

J Mol Biol. 1999 Apr 30;288(2):203-11.

PMID: 10329137 [PubMed - indexed for MEDLINE]

13:

Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation.

Betancourt T, Brown B, Brannon-Peppas L.

Nanomed. 2007 Apr;2(2):219-32.

PMID: 17716122 [PubMed - indexed for MEDLINE]

14:

Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.

Ríhová B, Jelínková M, Strohalm J, Subr V, Plocová D, Hovorka O, Novák M, Plundrová D, Germano Y, Ulbrich K.

J Control Release. 2000 Feb 14;64(1-3):241-61.

PMID: 10640661 [PubMed - indexed for MEDLINE]

15:

Future directions of liposome- and immunoliposome-based cancer therapeutics.

Park JW, Benz CC, Martin FJ.

Semin Oncol. 2004 Dec;31(6 Suppl 13):196-205. Review.

PMID: 15717745 [PubMed - indexed for MEDLINE]

16:

Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.

Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B.

Bioconjug Chem. 2002 Mar-Apr;13(2):206-15.

PMID: 11906257 [PubMed - indexed for MEDLINE]

17:

Therapeutic nanoparticles for drug delivery in cancer.

Cho K, Wang X, Nie S, Chen ZG, Shin DM.

Clin Cancer Res. 2008 Mar 1;14(5):1310-6. Review.

PMID: 18316549 [PubMed - indexed for MEDLINE]

18:

Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics.

MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP, Haasdyk JE, Dickson KA, Brahmbhatt VN, Pattison ST, James AC, Al Bakri G, Straw RC, Stillman B, Graham RM, Brahmbhatt H.

Cancer Cell. 2007 May;11(5):431-45.

PMID: 17482133 [PubMed - indexed for MEDLINE]

19:

Interleukin-13 receptor-targeted nanovesicles are a potential therapy for glioblastoma multiforme.

Madhankumar AB, Slagle-Webb B, Mintz A, Sheehan JM, Connor JR.

Mol Cancer Ther. 2006 Dec;5(12):3162-9.

PMID: 17172420 [PubMed - indexed for MEDLINE]

20:

[Development of antituberculous drugs: current status and future prospects]

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID: 17240921 [PubMed - indexed for MEDLINE]

Recent Activity